After eliminating debt, cutting dilution, and driving revenue, Opus launches a bold incubation strategy— targeting 3–5 spin-offs in 24 months to maximize shareholder value A Disciplined Vision for 2025 and Beyond MIAMI, April 22, 2025 /PRNewswire/ -- Opus Holdings, Inc. (OTC: CATV), pending name and ticker change to Opus Holdings, Inc. (OTC: OPHD), proudly announces the official appointment of two other individuals in our leadership team. Following the strategic appointment of CEO Susan Ward, the Company no ...

Core Insights - Christie's International Real Estate is expanding its presence in the Asia-Pacific region with the launch of its first exclusive affiliate in New Zealand, Thomas Estates [1][4] Company Overview - Thomas Estates is co-led by award-winning agents Russell and Angela Thomas, focusing on the Waikato region, including Hamilton, Cambridge, and upscale suburbs like Tamahere, as well as Auckland and Bay of Plenty [2] - The Thomases have a 12-year track record in luxury real estate, specializing in high-value properties, with sales reaching up to NZD$18,000,000 (USD$10,200,000) [3] - Luxury properties in Hamilton typically range from NZD$2,000,000 to NZD$6,000,000 (USD$1,100,000 to USD$3,400,000) [3] Market Positioning - As an affiliate of Christie's International Real Estate, Thomas Estates will leverage the brand's global luxury network, which includes affiliates in 50 countries and territories, providing clients with local and international exposure [4][8] - The partnership with Christie's offers exclusive marketing opportunities, enhancing the visibility of properties in New Zealand and abroad [5] Regional Insights - The Waikato region is known for its outdoor activities and sports, particularly in the Waipa District, which is significant for New Zealand's thoroughbred industry and Olympic training [6] - Hamilton is characterized by a vibrant mix of business, culture, and tourism, with ongoing development initiatives aimed at long-term growth [6] Regulatory Environment - New Zealand currently has restrictions on real estate purchases by foreign residents, but there are indications from Deputy Prime Minister Winston Peters about a potential relaxation of these policies, which could positively impact the real estate market [7]

Core Insights - Wells Fargo is making the largest investment in talent in the 25-year history of its Technology Banking organization, expanding its team by 20% over the past year and planning to add more bankers this year [1][2] Group 1: Team Expansion - The Technology Banking team added 20 bankers in 2024 and plans to add another 10 this year [2] - The growth of the Technology Banking team is driven by the U.S. tech sector's growth, including increased IT spending, artificial intelligence investments, and a renewed focus on innovation [3] Group 2: Strategic Focus - Technology Banking is a priority sector for Wells Fargo, with a specialized team committed to building long-term relationships and delivering strategic solutions to help companies scale and succeed [4] - The Technology Banking Group supports clients in all stages of the business cycle, focusing on software, FinTech, eCommerce, semiconductor, business and technology services, and sustainable tech [4] Group 3: Operational Insights - The Technology Banking Group has hubs in major cities including Austin, Boston, Chicago, Denver, Los Angeles, New York City, Phoenix, the San Francisco Bay Area, and Utah [5] - Wells Fargo has successfully grown fee-based revenue across many business segments while reducing dependence on net interest income during the first quarter [5] - The bank is increasingly focusing on non-interest income streams such as investment advisory, treasury management, and merchant services to buffer against market volatility and interest rate uncertainty [6]

The White House really wants to get a deal to sell Chinese short-video app TikTok to a US company and remove all possibilities of the Mainland using it as a way to spy on Americans.Except, apparently, one Big Tech firm that Team Trump isn’t so keen on: Online retail giant Amazon, On The Money has learnedI know what you’re saying, hasn’t The Donald and Amazon founder Jeff Bezos (the dude he used to call “Jeff Bozo” because he owns the Trump hating Washington Post) patched things up? Bezos was at the inaugura ...

ParagonX is a holding company with a portfolio of companies in construction and logistics, as outlined in its respective OTC filings. The Company is a Nevada corporation and was founded in the late nineties. The Company website is www.paragonX.com FORWARD-LOOKING STATEMENTS: This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that do not relate to matters of historical fact should be considered ...

About YY Holdings Limited: YY Group Holding Limited is a Singapore-based data and technology-driven company that specializes in creating enterprise intelligent labor matching services and smart cleaning solutions. Rooted in innovation and a commitment to user-centric experiences, YY Circle leverages app-based technology to optimize the labor sourcing market and the Internet of Things to revolutionize the cleaning industry. For more information on the Company, please log on to https://yygroupholding.com/. Si ...

Core Insights - Nxera Pharma has appointed Mr. Kiyoshi Kaneko as Chief Commercial Officer and promoted Ms. Mariko Nakafuji to Chief Legal Officer, effective April 1, 2025 [1][4] Group 1: Leadership Appointments - Mr. Kiyoshi Kaneko brings extensive experience in business development and corporate strategy from his previous roles at AstraZeneca and Luye Life Sciences Group Japan [2] - Ms. Mariko Nakafuji, who joined Nxera in 2021, played a significant role in the acquisition of Idorsia Pharmaceuticals' Japan and South Korean businesses and has a background in corporate M&A and private equity [3] Group 2: Company Strategy and Vision - The appointments are aimed at enhancing Nxera's commercial activities in Japan and positioning the company as a leading biopharma business in the region [4][5] - Mr. Kaneko expressed confidence in Nxera's ability to capitalize on opportunities in the Japanese pharmaceutical industry, emphasizing the company's focus on commercialization capabilities [5] Group 3: Company Overview - Nxera Pharma is a technology-powered biopharma company focused on developing specialty medicines for unmet patient needs in Japan and globally [6] - The company has over 30 active programs in its pipeline, targeting areas such as neurology, gastrointestinal disorders, immunology, metabolic disorders, and rare diseases [7] - Nxera employs over 350 people across key locations including Tokyo, Osaka, London, Cambridge, Basel, and Seoul, and is listed on the Tokyo Stock Exchange [8]

Core Insights - The campaign "Sunscreen You Can't See" emphasizes the effectiveness of Neutrogena® Ultra Sheer® Sunscreen, highlighting its high-SPF mineral formula that provides protection from UV rays while being lightweight and invisible on the skin [1][2] Product Features - Neutrogena® Ultra Sheer® Sunscreen offers broad-spectrum UVA/UVB protection through proprietary Helioplex® and Purescreen® Technology, ensuring a fast-absorbing, ultra-light, and non-greasy application [2] - The product is designed for daily use, aiming to make sunscreen application effortless and enjoyable [2] Marketing Strategy - The company aims to engage younger audiences by using humor and cultural relevance in its messaging about sun safety and daily sunscreen use [3] - Neutrogena® plans to enhance its commitment to sun safety education in 2025, increasing dermatologist engagement and providing sunscreen samples at events like the Coachella Valley Music and Arts Festival [3][4] Community Engagement - The brand will serve as the official sun care sponsor for the 2025 World Surf League, promoting sun protection for beach and water activities [4] - Neutrogena® has partnered with Young Minds Inspired to create the Sun Safety for All program, which aims to educate students nationwide about sun protection [4] Company Background - Kenvue Inc. is recognized as the world's largest pure-play consumer health company by revenue, with a portfolio of iconic brands including Neutrogena®, which has been developing skincare solutions for over 90 years [5][6]

Core Insights - Defence Therapeutics Inc. has appointed Dr. Elias Theodorou as Chief Operating Officer, effective April 2025, to enhance its management team and accelerate development programs [2][3] - Dr. Theodorou brings over 25 years of experience in cancer research and innovative drug delivery systems, which aligns with Defence's mission to advance its proprietary Accum® technology [3][4] - The company has granted Dr. Theodorou 350,000 incentive stock options, with 100,000 vesting immediately and the remainder vesting in one year, exercisable at $1.07 per share for ten years [3] Company Overview - Defence Therapeutics is a clinical-stage biotechnology company focused on developing radio-immuno-conjugate and antibody-drug conjugate (ADC) products using its proprietary platform [4] - The core technology, Accum®, enables precision delivery of therapeutic agents to target cells, aiming to improve efficacy against cancer and infectious diseases [5]

Core Viewpoint - Opus Holdings, Inc. is undergoing a significant transformation by changing its name from 4Cable TV International, Inc. and shifting its business model to focus on incubating private companies and guiding them to public market success [1][2]. Business Model Transformation - The new business model involves acquiring and developing private companies with high growth potential, providing them with necessary resources and expertise for transitioning into independent public entities [2][5]. - Opus Holdings has identified its first acquisition target and is negotiating with a new management team experienced in corporate finance and public market transitions [2][6]. - Current subsidiaries under the previous name will be merged out, with the current CEO overseeing this process, which is expected to yield dividends for CATV shareholders [2][3]. Dividend Guidelines - Following the merger, Opus Holdings will file a Corporate Action with FINRA to establish the dividend's record date, payment date, and amount, adhering to FINRA's notification requirements [3][4]. Future Growth Strategy - The company aims to identify high-potential private companies in sectors such as biotech, cannabis, technology, and consumer goods, providing them with financial and strategic guidance [5][6]. - Opus Holdings plans to transition these companies into public entities through IPOs or reverse mergers, potentially issuing dividends to shareholders upon successful spin-offs [5][6]. Investor Engagement - Opus Holdings is actively inviting private businesses and investors to participate in its growth phase, with plans to host discussions about its transformation and future plans [7][8]. - The company is implementing an aggressive growth strategy that includes networking, partnerships, trade shows, targeted marketing, and referral programs to source acquisition candidates [6][7].